meloxicam
meloxicam is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: meloxicam; Generic name: MELOXICAM; Drug class: Nonsteroidal Anti-inflammatory Drug [EPC].
| Brand name | meloxicam |
|---|---|
| Generic name | MELOXICAM |
| Drug class | Nonsteroidal Anti-inflammatory Drug [EPC] |
| Manufacturer | Quality Care Products LLC |
| Used for | 1. INDICATIONS AND USAGE Meloxicam tablets are a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) ( 1.1 ) Rheumatoid Arthritis (RA) ( 1.2 ) 1.1 Osteoarthritis (OA) Meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [ see Clinical Studies (14.1) ]. 1.2 Rheumatoid Arthritis (RA) Meloxicam tablet are indicated for relief of the signs and symptoms of rheumatoid arthritis [ see Clinical Studies (14.1) ]. |
| Dosage | 2. DOSAGE AND ADMINISTRATION Use the lowest effective dose for the shortest duration consistent with individual treatment goals for the individual patient. • OA ( 2.2 ) and RA ( 2.3 ): Starting dose: 7.5 mg once daily Dose may be increased to 15 mg once daily 2.1 General Instructions Carefully consider the potential benefits and risks of meloxicam tablets USP and other treatment options before deciding to use meloxicam tablets USP. Use the lowest effective dose for the shortest duration consiste |
| Warnings | WARNING: RISK OF CARDIOVASCULAR AND GASTROINTESTINAL EVENTS WARNING: CARDIOVASCULAR and GASTROINTESTINAL RISKS See full prescribing information for complete boxed warning . Cardiovascular Risk NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk. ( 5.1 ) Meloxicam table |
| Active ingredient(s) | MELOXICAM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0edec862-f3e8-46f6-b6d0-de0bc21dd3fb |